Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,512 results
- WATERIndependent statistical analysis of Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02505919).
- WAVEIndependent statistical analysis of Durvalumab Long-Term Safety and Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04078152).
- WEARIT-FRIndependent statistical analysis of LifeVest Safety and Efficacy in Real Life Settings in France: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03319160).
- Web-based Smoking Cessation Program for Tribal College Students: Complete Statistical AnalysisIndependent statistical analysis of Web-based Smoking Cessation Program for Tribal College Students: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02050308).
- Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0: Complete Statistical AnalysisIndependent statistical analysis of Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Weight-based Dosing in Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of Weight-based Dosing in Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02586012).
- WH-PACTIndependent statistical analysis of Implementation of Women's Health Patient Aligned Care Teams: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039856).
- WHISPERIndependent statistical analysis of Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment: Complete Statistical AnalysisIndependent statistical analysis of Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer: primary endpoint results, effect estimate with confidence…
- WI223281Independent statistical analysis of Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Willow 3Independent statistical analysis of A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04194892).
- WISARDIndependent statistical analysis of Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With…
- WISEIndependent statistical analysis of Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Women’s Health Communication Study: Complete Statistical AnalysisIndependent statistical analysis of Women's Health Communication Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05359952).
- Women’s MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC: Complete Statistical AnalysisIndependent statistical analysis of Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention: Complete Statistical AnalysisIndependent statistical analysis of Work Should Not Hurt You: Reduction of Hazardous Exposures in Small Businesses Through a Community Health Worker Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Worksite Phone Counseling for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Worksite Phone Counseling for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02730260).
- WP02 Continued Access Study: Complete Statistical AnalysisIndependent statistical analysis of WP02 Continued Access Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04862156).
- Wrist Fracture Evaluation With a Desktop Orthopedic Tomosynthesis System: Complete Statistical AnalysisIndependent statistical analysis of Wrist Fracture Evaluation With a Desktop Orthopedic Tomosynthesis System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03993691).
- WWIndependent statistical analysis of Warm Water for Unsedated Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905554).
- X-3 Polyethylene Survival Outcomes Study: Complete Statistical AnalysisIndependent statistical analysis of X-3 Polyethylene Survival Outcomes Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00493792).
- X-Seal EU Post-Market Clinical Follow-Up Protocol: Complete Statistical AnalysisIndependent statistical analysis of X-Seal EU Post-Market Clinical Follow-Up Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02406612).
- X-TOLEIndependent statistical analysis of A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- X-TRAPIndependent statistical analysis of Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Xeloda (Capecitabine) and External Beam Radiation: Complete Statistical AnalysisIndependent statistical analysis of Xeloda (Capecitabine) and External Beam Radiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00916578).
- Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation: Complete Statistical AnalysisIndependent statistical analysis of Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- XEPADIndependent statistical analysis of An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- XIENCE 28 Global Study: Complete Statistical AnalysisIndependent statistical analysis of XIENCE 28 Global Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03355742).
- XIENCE PRIME Japan Post-Marketing Surveillance (PMS): Complete Statistical AnalysisIndependent statistical analysis of XIENCE PRIME Japan Post-Marketing Surveillance (PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01721096).
- XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS): Complete Statistical AnalysisIndependent statistical analysis of XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Xplore2Independent statistical analysis of Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03022708).
- Y-ACTIndependent statistical analysis of Yoga in Adult Cancer: A Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02309112).
- Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210): Complete Statistical AnalysisIndependent statistical analysis of Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- YNQIndependent statistical analysis of Yes/No Questionnaire for Aphasic Patients (YNQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03257696).
- Yoga and Female Concussion: Complete Statistical AnalysisIndependent statistical analysis of Yoga and Female Concussion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07170488).
- Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Young Men and Media Study: Complete Statistical AnalysisIndependent statistical analysis of Young Men and Media Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04109443).
- YPPProConIndependent statistical analysis of Young Parents Program, Project Connect: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01379924).
- ZamCATIndependent statistical analysis of Zambia Chlorhexidine Application Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01241318).
- ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin: Complete Statistical AnalysisIndependent statistical analysis of ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ZEAL UNLOCKIndependent statistical analysis of A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Zenith® Low Profile AAA Endovascular Graft: Complete Statistical AnalysisIndependent statistical analysis of Zenith® Low Profile AAA Endovascular Graft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02535065).
- Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: Complete Statistical AnalysisIndependent statistical analysis of Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ZESCAIndependent statistical analysis of Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ZEUSIndependent statistical analysis of Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00493467).
- Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01490723).